Centrosome amplification drives chromosomal instability in breast tumor development

Earlier studies of invasive breast tumors have shown that 60–80% are aneuploid and ≈80% exhibit amplified centrosomes. In this study, we investigated the relationship of centrosome amplification with aneuploidy, chromosomal instability, p53 mutation, and loss of differentiation in human breast tumors. Twenty invasive breast tumors and seven normal breast tissues were analyzed by fluorescence in situ hybridization with centromeric probes to chromosomes 3, 7, and 17. We analyzed these tumors for both aneuploidy and unstable karyotypes as determined by chromosomal instability. The results were then tested for correlation with three measures of centrosome amplification: centrosome size, centrosome number, and centrosome microtubule nucleation capacity. Centrosome size and centrosome number both showed a positive, significant, linear correlation with aneuploidy and chromosomal instability. Microtubule nucleation capacity showed no such correlation, but did correlate significantly with loss of tissue differentiation. Centrosome amplification was detected in in situ ductal carcinomas, suggesting that centrosome amplification is an early event in these lesions. Centrosome amplification and chromosomal instability occurred independently of p53 mutation, whereas p53 mutation was associated with a significant increase in centrosome microtubule nucleation capacity. Together, these results demonstrate that independent aspects of centrosome amplification correlate with chromosomal instability and loss of tissue differentiation and may be involved in tumor development and progression. These results further suggest that aspects of centrosome amplification may have clinical diagnostic and/or prognostic value and that the centrosome may be a potential target for cancer therapy.

[1]  I. Ellis,et al.  Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. , 2002, Histopathology.

[2]  W. B. Smith,et al.  A Role for Endothelial NO Synthase in LTP Revealed by Adenovirus-Mediated Inhibition and Rescue , 1996, Science.

[3]  W. Lingle,et al.  Methods for the analysis of centrosome reproduction in cancer cells. , 2001, Methods in cell biology.

[4]  D. Santini,et al.  Clone heterogeneity in diploid and aneuploid breast carcinomas as detected by FISH. , 2001, Cytometry.

[5]  J. Ingle,et al.  Centrosome hypertrophy in human breast tumors: implications for genomic stability and cell polarity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[6]  L. Liotta,et al.  Centrosome defects can account for cellular and genetic changes that characterize prostate cancer progression. , 2001, Cancer research.

[7]  S. Noguchi,et al.  Chromosomal instability detected by fluorescence in situ hybridization in Japanese breast cancer patients. , 2001, Clinica chimica acta; international journal of clinical chemistry.

[8]  D. Visscher,et al.  Analysis of chromosome aneuploidy in breast carcinoma progression by using fluorescence in situ hybridization. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[9]  M. Fiegl,et al.  Malignant cell detection by fluorescence in situ hybridization (FISH) in effusions from patients with carcinoma. , 2000, Human pathology.

[10]  H Knecht,et al.  Centrosome defects and genetic instability in malignant tumors. , 1998, Cancer research.

[11]  W. Lingle,et al.  Altered centrosome structure is associated with abnormal mitoses in human breast tumors. , 1999, The American journal of pathology.

[12]  Patrick E Carroll,et al.  Centrosome hyperamplification in human cancer: chromosome instability induced by p53 mutation and/or Mdm2 overexpression , 1999, Oncogene.

[13]  Y. Miyoshi,et al.  Association of centrosomal kinase STK15/BTAK mRNA expression with chromosomal instability in human breast cancers , 2001, International journal of cancer.

[14]  H. Gabbert,et al.  Mechanisms of tumor metastasis: cell biological aspects and clinical implications , 2000, Journal of Cancer Research and Clinical Oncology.

[15]  J Isola,et al.  Molecular cytogenetics of primary breast cancer by CGH , 1998, Genes, chromosomes & cancer.

[16]  K. Fukasawa,et al.  Genomic convergence and suppression of centrosome hyperamplification in primary p53-/- cells in prolonged culture. , 2000, Experimental cell research.

[17]  W. Lingle,et al.  The role of the centrosome in the development of malignant tumors. , 2000, Current topics in developmental biology.

[18]  E. Schröck,et al.  Centrosome amplification and instability occurs exclusively in aneuploid, but not in diploid colorectal cancer cell lines, and correlates with numerical chromosomal aberrations , 2000, Genes, chromosomes & cancer.

[19]  J. Eyfjörd,et al.  p53 abnormality and chromosomal instability in the same breast tumor cells. , 2000, Cancer genetics and cytogenetics.

[20]  L. Hartmann,et al.  Chromosome-specific aneusomy in carcinoma of the breast. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[21]  J W Gray,et al.  Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[22]  J. Salisbury,et al.  The Contribution of Epigenetic Changes to Abnormal Centrosomes and Genomic Instability in Breast Cancer , 2001, Journal of Mammary Gland Biology and Neoplasia.

[23]  T. Sauer,et al.  Numerical aberrations of chromosome 17 in interphase cell nuclei of breast carcinoma cells: lack of correlation with abnormal expression of p53, neu and nm23 protein , 1998, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[24]  S. Martino,et al.  Prediction of Node-Negative Breast Cancer Outcome by Histologic Grading and S-Phase Analysis by Flow Cytometry: An Eastern Cooperative Oncology Group Study (2192) , 2001, American journal of clinical oncology.

[25]  K. Kinzler,et al.  Genetic instability in colorectal cancers , 1997, Nature.

[26]  S N Thibodeau,et al.  Denaturing high performance liquid chromatography (DHPLC) used in the detection of germline and somatic mutations. , 1998, Nucleic acids research.

[27]  D. Medina,et al.  Expression of a p53 mutant in the epidermis of transgenic mice accelerates chemical carcinogenesis , 1998, Oncogene.

[28]  A. Schäffer,et al.  Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. , 1997, Cancer research.

[29]  Jian Kuang,et al.  Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation , 1998, Nature Genetics.

[30]  Th. Boveri,et al.  The origin of malignant tumors , 1929 .

[31]  J. Isola,et al.  Chromosomal rearrangements and oncogene amplification precede aneuploidization in the genetic evolution of breast cancer. , 2001, Cancer research.

[32]  G. Woude,et al.  Abnormal Centrosome Amplification in the Absence of p53 , 1996, Science.

[33]  K. Münger,et al.  Human papillomavirus type 16 E7 oncoprotein-induced abnormal centrosome synthesis is an early event in the evolving malignant phenotype. , 2001, Cancer research.

[34]  G. Reifenberger,et al.  Centrosome amplification as a possible mechanism for numerical chromosome aberrations in cerebral primitive neuroectodermal tumors with TP53 mutations , 1999, Cytogenetic and Genome Research.

[35]  B. Brinkley,et al.  Managing the centrosome numbers game: from chaos to stability in cancer cell division. , 2001, Trends in cell biology.

[36]  C. Bartoli,et al.  Detection of TP53 mutation, loss of heterozygosity and DNA content in fine-needle aspirates of breast carcinoma. , 1998, British Journal of Cancer.

[37]  Y. A. Minamishima,et al.  Correlation between centrosome abnormalities and chromosomal instability in human pancreatic cancer cells. , 2001, Cancer genetics and cytogenetics.

[38]  D J O'Kane,et al.  A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma. , 2000, The Journal of urology.

[39]  S. Edge,et al.  Prognostic factors in breast cancer , 2005 .